The University of Chicago Header Logo

Connection

Hedy Kindler to Nucleic Acid Synthesis Inhibitors

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Nucleic Acid Synthesis Inhibitors.
Hedy Kindler
Connection Strength
0.209
Nucleic Acid Synthesis Inhibitors
  1. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial. Nat Med. 2021 11; 27(11):1910-1920.
    View in: PubMed
    Score: 0.209
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.